Thus, combining Wnt7a with RB and sAPPα in hMSCs may enable cholinergic neurons to be generated more efficiently, providing a potential therapy for Alzheimer's disease. The gene discussed is RB1; the disease is early-onset autosomal dominant Alzheimer disease.